1. A pulmonary rehabilitation program reduces hospitalizations in chronic obstructive pulmonary disease patients: A cost-effectiveness study
- Author
-
Toubes-Navarro, Maria Elena, Gude-Sampedro, Francisco, Álvarez-Dobaño, José Manuel, Reyes-Santias, Francisco, Rábade-Castedo, Carlos, Rodríguez-García, Carlota, Lado-Baleato, Óscar, Lago-Fidalgo, Raquel, Sánchez-Martínez, Noelia, Ricoy-Gabaldón, Jorge, Casal-Mouriño, Ana, Abelleira-Paris, Romina, Riveiro-Blanco, Vanessa, Zamarrón-Sanz, Carlos, Rodríguez-Núñez, Nuria, Lama-López, Adriana, Ferreiro-Fernández, Lucía, and Valdés-Cuadrado, Luis
- Subjects
Statistics ,Care and treatment ,Patient outcomes ,Hospitalization -- Statistics -- Patient outcomes ,Chronic obstructive lung disease -- Care and treatment -- Patient outcomes -- Statistics ,Respiratory therapy -- Statistics -- Patient outcomes ,Hospital care -- Statistics -- Patient outcomes ,Lung diseases, Obstructive -- Care and treatment -- Patient outcomes -- Statistics - Abstract
Author(s): Maria Elena Toubes-Navarro [1]; Francisco Gude-Sampedro [2]; José Manuel Álvarez-Dobaño [3,4]; Francisco Reyes-Santias [5]; Carlos Rábade-Castedo [1]; Carlota Rodríguez-García [1]; Óscar Lado-Baleato [6,7]; Raquel Lago-Fidalgo [2,8]; Noelia Sánchez-Martínez [2,8]; [...], : BACKGROUND: Although pulmonary rehabilitation (PR) is recommended in patients with chronic obstructive pulmonary disease (COPD), there is a scarcity of data demonstrating the cost-effectiveness and effectiveness of PR in reducing exacerbations. METHODS: A quasi-experimental study in 200 patients with COPD was conducted to determine the number of exacerbations 1 year before and after their participation in a PR program. Quality of life was measured using the COPD assessment test and EuroQol-5D. The costs of the program and exacerbations were assessed the year before and after participation in the PR program. The incremental cost-effectiveness ratio (ICER) was estimated in terms of quality-adjusted life years (QALYs). RESULTS: The number of admissions, length of hospital stay, and admissions to the emergency department decreased after participation in the PR program by 48.2, 46.6, and 42.5, respectively (P < 0.001 for all). Results on quality of life tests improved significantly (P < 0.001 for the two tests). The cost of PR per patient and the cost of pre-PR and post-PR exacerbations were €1867.7 and €7895.2 and €4201.9, respectively. The PR resulted in a cost saving of €1826 (total, €365,200) per patient/year, and the gain in QALYs was+0.107. ICER was -€17,056. The total cost was CONCLUSIONS: PR contributes to reducing the number of exacerbations in patients with COPD, thereby slowing clinical deterioration. In addition, it is cost-effective in terms of QALYs. Keywords: Chronic obstructive pulmonary disease, cost-effectiveness study, exacerbations, pulmonary rehabilitation
- Published
- 2023
- Full Text
- View/download PDF